Below is a listing of treatments and therapies for psoriasis and psoriatic arthritis. Click on one to read more information or connect with others currently using it.
Abrilada (adalimumab-afzb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis.
Acthar Gel (repository corticotropin injection) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for short-term use with other treatment during a flare of…
read moreAmjevita (adalimumab-atto) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis.
Avsola (infliximab-axxq) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic severe plaque psoriasis.
Bimzelx (bimekizumab-bkzx) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in…
read moreOverview
Calcitrene is approved by the U.S. Food and Drug Administration (FDA) for the treatment of plaque psoriasis in adults. It is prescribed for individuals with mild to moderate plaque psoriasis and should not be…
Cimzia (certolizumab pegol) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque…
read moreCosentyx (secukinumab) is a biologic medicine approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis in…
read moreCyltezo (adalimumab-adbm) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis and active…
read moreDovonex (calcipotriene) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis.
These insights are…
Duobrii (halobetasol propionate and tazarotene) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with plaque psoriasis.
Enbrel (etanercept) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in adults…
read moreOverview
Erelzi is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat psoriatic arthritis and moderate to severe chronic plaque psoriasis in adults. Erelzi may be referred to by… read more
Eticovo (etanercept-ykro) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children 4 years and older with moderate to severe plaque psoriasis or…
read moreHadlima (adalimumab-bwwd) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis and active…
read moreHulio (adalimumab-fkjp) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis or active…
read moreHumira (adalimumab) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in adults.
… read moreHyrimoz (adalimumab-adaz) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis and active…
read moreIcotyde (icotrokinra) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 12 and older with moderate to severe plaque psoriasis…
read moreIdacio (adalimumab-aacf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis and active…
read moreIlumya (tildrakizumab-asmn) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe plaque…
read moreImuldosa (ustekinumab-srlf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 6 and older with moderate to severe plaque…
read moreInflectra (infliximab-dyyb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic severe plaque psoriasis.
Ixifi (infliximab-qbtx) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic severe plaque psoriasis.
The drug maintains its official FDA…
read moreOverview
Neoral is a prescription medication originally approved by the U.S. Food and Drug Administration (FDA) in 1983. Neoral is approved to treat severe psoriasis in adults who do not respond to other treatments.… read more
Orencia (abatacept) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat people ages 2 and older with active psoriatic…
read moreOtezla (apremilast) is an oral medication called a phosphodiesterase 4 (PDE4) inhibitor, approved by the U.S. Food and Drug Administration (FDA) for…
read moreOtulfi (ustekinumab-aauz) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 6 and older with moderate to severe plaque…
read morePyzchiva (ustekinumab-ttwe) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 6 and older with moderate to severe plaque…
read moreRasuvo (methotrexate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to control symptoms of severe, hard-to-treat, disabling…
read moreRemicade (infliximab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic severe plaque psoriasis.
Renflexis (infliximab-abda) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic severe plaque psoriasis.
Rinvoq (upadacitinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 2 and older with active…
read moreSelarsdi (ustekinumab-aekn) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 6 and older with moderate to severe plaque…
read moreOverview
Siliq is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe psoriasis in adults. Siliq may be prescribed in cases where systemic therapy and phototherapy are… read more
Simlandi (adalimumab-ryvk) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis and active…
read moreSimponi (golimumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with active psoriatic arthritis.
Simponi Aria (golimumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat active psoriatic arthritis in people 2 years…
read moreSkyrizi (risankizumab-rzaa) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for adults with moderate to severe psoriasis…
read moreSoriatane (acitretin) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with severe psoriasis.
These…
Sorilux (calcipotriene) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis of the scalp and body in adults and children ages 4 and older.
Sotyktu (deucravacitinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe plaque psoriasis.
Spevigo (spesolimab-sbzo) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat generalized pustular psoriasis (GPP) in adults and children ages 12…
read moreStarjemza (ustekinumab-hmny) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 6 and older with moderate to severe plaque psoriasis.
Stelara (ustekinumab) is a medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis in adults…
read moreSteqeyma (ustekinumab-stba) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 6 years and older with moderate to severe…
read moreTaclonex (calcipotriene/betamethasone dipropionate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis in people ages 12 years and older.
Taltz (ixekizumab) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis in…
read moreTazorac (tazarotene) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat people with plaque psoriasis.
Tazorac…
Tremfya (guselkumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe plaque psoriasis…
read moreTrexall (methotrexate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with severe psoriasis.
These…
Overview
Vectical is a prescription medication approved by the U.S. Food and Drug Administration (FDA) in 2009. Vectical is used to treat mild to moderate plaque psoriasis in adults 18 years and older. Vectical is also… read more
Vtama (tapinarof cream) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with plaque psoriasis.
Wezlana (ustekinumab-auub) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis in adults and children ages 6…
read moreWynzora (calcipotriene and betamethasone dipropionate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis in adults ages 18 and…
read moreXeljanz (tofacitinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults and children ages 2 years and older…
read moreYesintek (ustekinumab-kfce) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 6 years and older with moderate to severe…
read moreYuflyma (adalimumab-aaty) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis or active…
read moreYusimry (adalimumab-aqvh) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderate to severe chronic plaque psoriasis and active…
read moreZoryve (roflumilast) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat plaque psoriasis in certain adults and children…
read moreBecome a member to get even more